In our study, geldanamycin was found to downregulate the expression of HYOU1, inhibit lipid peroxidation, regulate lipid metabolism disorders, and exhibit antiviral, antioxidant, and anti-inflammatory activities. The gene discussed is HYOU1; the disease is Disorder of lipid metabolism.